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Iron–sulfur (Fe-S) clusters are ancient cofactors in cells and
participate in diverse biochemical functions, including electron
transfer and enzymatic catalysis. Although cell lines derived
from individuals carrying mutations in the Fe-S cluster biogen-
esis pathway or siRNA-mediated knockdown of the Fe-S assem-
bly components provide excellent models for investigating Fe-S
cluster formation in mammalian cells, these experimental strat-
egies focus on the consequences of prolonged impairment of
Fe-S assembly. Here, we constructed and expressed dominant–
negative variants of the primary Fe-S biogenesis scaffold protein
iron–sulfur cluster assembly enzyme 2 (ISCU2) in human
HEK293 cells. This approach enabled us to study the early met-
abolic reprogramming associated with loss of Fe-S– containing
proteins in several major cellular compartments. Using multiple
metabolomics platforms, we observed a 12-fold increase in
intracellular citrate content in Fe-S– deficient cells, a surge that
was due to loss of aconitase activity. The excess citrate was gen-
erated from glucose-derived acetyl-CoA, and global analysis of
cellular lipids revealed that fatty acid biosynthesis increased
markedly relative to cellular proliferation rates in Fe-S– defi-
cient cells. We also observed intracellular lipid droplet accumu-
lation in both acutely Fe-S– deficient cells and iron-starved
cells. We conclude that deficient Fe-S biogenesis and acute iron
deficiency rapidly increase cellular citrate concentrations, lead-
ing to fatty acid synthesis and cytosolic lipid droplet formation.
Our findings uncover a potential cause of cellular steatosis in
nonadipose tissues.
Iron–sulfur (Fe-S) clusters are ancient components of the
cellular machinery that provide essential cofactors for numer-
ous proteins. In addition to serving as a conduit for electron
transport in respiratory chain complexes, Fe-S clusters catalyze
chemical oxidation–reduction reactions and participate in cel-
lular regulatory signaling (1). In the nucleus, Fe-S clusters are
cofactors in several crucial DNA repair enzymes (2, 3), and Fe-S
clusters are essential for the function of the eukaryotic cytosolic
RNA polymerases (4). Thus, Fe-S proteins are essential for cell
survival and proliferation.
Fe-S assembly scaffolds have been a focus of attention since
their discovery in nitrogen-fixing bacteria (5, 6), and mutations
in the human Fe-S scaffold ISCU cause hereditary diseases in
humans (7, 8). In human cells, Fe-S clusters are assembled on a
multimeric complex containing the ISCU scaffold, cysteine
desulfurase NFS1, and accessory proteins ISD11 and frataxin
(9). Binding of the HSPA9/HSC20 chaperone/co-chaperone
system facilitates ATP-dependent transfer of the nascent Fe-S
clusters to recipient Fe-S proteins (10, 11), which is mediated by
LYR tripeptide motifs in recipient proteins that bind to the
HSC20 co-chaperone (12).
Fe-S clusters assembled on the ISCU scaffold are labile and
transient, and clusters are often lost during protein purifica-
tion, during exposure to oxygen, or by treatment with mild
reducing agents (13–15). The Fe-S cluster lability of ISCU has
been attributed to a conserved aspartate residue adjacent to one
of the Fe-S cluster–ligating cysteines (Asp-37 in Azotobacter
vinelandii NifU; Asp-71 in human ISCU) (13) and has been
proposed to confer the ability of the scaffold to release nascent
Fe-S clusters for transfer to recipient proteins (15, 16). A
mutant of IscU (NifUD37A) that more stably bound [2Fe-2S]
clusters (13) was later shown to trap the cysteine desulfurase
IscS (14) and to inhibit transfer of Fe-S clusters to purified apo-
aconitase in vitro (16), resulting in a dominant–negative growth
phenotype in A. vinelandii (14). Molecular modeling based on
the IscU-IscS crystal structure suggested that the conserved
aspartate in IscU served as a fourth ligand for the nascent [2Fe-
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2S] cluster, allowing dissociation of a cluster-ligating cysteine in
IscS and associated conformational changes (15).
Although complete loss of ISCU is lethal in all organisms
tested to date (14, 17, 18), assessment of ISCU deficiency on
cellular metabolism in mammalian cells has been limited to
knockdown experiments (19) and/or study of patient tissues
that are naturally deficient in ISCU (7, 18, 20, 21). In this study,
we expressed dominant–negative mitochondrial ISCU variant
proteins in a human cell line (HEK293) to investigate the effects
of acute loss of Fe-S enzymes on cellular metabolism. We found
that high cellular citrate levels and lipid accumulation are early
and acute metabolic consequences of Fe-S cluster deficiency.
These findings highlight the remodeling of cellular metabolism
that occurs during acute iron deficiency and/or defective Fe-S
cluster assembly and draw our attention to a previously unrec-
ognized mechanism of intracellular lipid droplet accumulation,
which is a process underlying numerous disease pathologies
(e.g. see Ref. 22).
Results
ISCU variants disrupt cell growth and mitochondrial
morphology
ISCU is the main scaffold protein upon which nascent Fe-S
clusters are first assembled and then transferred to recipient
proteins (9). Spectroscopic studies and crystallography have
identified the crucial cysteine residues in the NifU/ISCU pro-
tein that are important for coordination of a labile [2Fe-2S]
cluster in the scaffold (Fig. 1A). We used site-directed mutagen-
esis of the human mitochondrial ISCU2 ORF (hISCU2) that
contained a C-terminal Myc tag sequence. ISCU2D71A-Myc
contains a mutation analogous to that previously reported in
the A. vinelandii NifU scaffold (D37A) (13); (Fig. 1B). The
D71A substitution in hISCU2 was predicted to stabilize the
Fe-S cluster on the ISCU scaffold by decreasing solvent acces-
sibility (13). In addition, we constructed an ISCU2C69S-Myc
mutant sequence that we predicted would be unable to effec-
tively ligate a nascent Fe-S cluster (13), as this cysteine residue is
a crucial iron-coordinating ligand of the nascent Fe-S cluster
(Fig. 1C) (15).
To evaluate the functionality of our ISCU constructs, we sta-
bly integrated them into HEK293 Flp-InTM cells, in which
transgene expression was tightly repressed until doxycycline
was added to the culture medium. Control cell lines stably har-
boring either empty vector or Myc-tagged GFP were also gen-
erated. Immunoblotting demonstrated robust expression of the
WT and the two mutant ISCU constructs in the cells (Fig. 1D).
Notably, significant levels of the mitochondrial precursor ISCU
protein were observed during overexpression of all three ISCU2
constructs (Fig. 1D, arrows). Expression of the ISCU binding
partners NFS1, ISD11, and frataxin was consistent in all of the
samples; however, the band corresponding to the partially pro-
cessed intermediate mitochondrial precursor of frataxin (23)
was not present in the lysates from cells expressing either
ISCU2D71A or ISCU2C69S mutant constructs (Fig. 1D, asterisk).
We immunoprecipitated the recombinant WT or mutant ISCU
proteins from these cell lysates using anti-Myc beads and ana-
lyzed the eluates for the presence of known ISCU binding part-
ners NFS1, ISD11, and frataxin (Fig. 1E). We observed abun-
dant amounts of immunoprecipitated ISCU and found that
NFS1 and ISD11 remained stably bound to ISCU during the
immunoprecipitation procedure (Fig. 1E, middle panels); how-
ever, no frataxin protein was detected (Fig. 1E, bottom), proba-
bly due to the transient nature of its interaction with the NFS1-
ISD11-ISCU initial complex. Together, these data suggest that
the mutant ISCU2D71A or ISCU2C69S proteins retained the abil-
ity to bind stably to two proteins of the initial Fe-S assembly
machinery in vivo.
Using an Incucyte FLRTM live-cell imager, we found that cell
growth was halted in ISCU2D71A cells 12 h following induc-
tion of transgene expression, and cells remained quiescent for
the remainder of the experiment (Fig. 1F). Cells expressing
ISCU2C69S protein also showed diminished cell growth,
whereas cells expressing WT ISCU2 (ISCU2WT) showed no
appreciable change in proliferation rate. The growth defect in
cells expressing ISCU2D71A and ISCU2C69S proteins appeared
to be cytostatic, as the cells did not detach from the dish and die
even after 96 h of protein induction. We also evaluated mito-
chondrial morphology by EM and found that, in contrast to
cells expressing GFP (Fig. 1G) or ISCU2WT (Fig. 1H), cells
expressing ISCU2D71A (Fig. 1I) and ISCU2C69S (Fig. 1J)
showed dramatic alterations in mitochondrial morphology
characterized by swollen mitochondria with disruption of
cristae. These observations suggested that profound meta-
bolic alterations were taking place in the cells following
expression of ISCU2D71A and ISCU2C69S.
Cells expressing ISCU variants lose aconitase activity and
activate iron-responsive element (IRE)-binding activity of IRP1
and IRP2
Loss of ISCU function, either as a result of siRNA-mediated
knockdown in cultured cells (19) or in patients due to a splicing
mutation of ISCU (7, 8), results in an inability of mitochondrial
and cytosolic aconitases to acquire the [4Fe-4S] clusters needed
for their enzymatic function. We evaluated aconitase activity
using native gel activity assay (19) in our HEK293 cells (Fig. 2A).
The results demonstrated that cells expressing ISCU2D71A or
ISCU2C69S had undetectable levels of mitochondrial and cyto-
solic aconitase activities (Fig. 2A). In contrast, the IRE2
mRNA-binding activities of IRP1 and IRP2 robustly increased
in cells expressing ISCU2D71A or ISCU2C69S (Fig. 2B), indi-
cating that cytosolic iron levels were low.
We performed a time course experiment in which cells har-
boring empty vector, ISCU2WT,ISCU2D71A, or ISCU2C69S were
2 The abbreviations used are: IRE, iron-responsive element; HSQC, heteronu-
clear single quantum coherence; IC, ion chromatography; UHR, ultra-high-
resolution; FTMS, Fourier transform mass spectrometry; TOCSY, total
correlation spectroscopy; BODIPY, 4,4-difluoro-1,3,5,7,8-pentamethyl-4-
bora-3a,4a-diaza-s-indacene; DSS-d6, deuterated 4,4-dimethyl-4-silapen-
tane-1-sulfonic acid; DAPI, 4,6-diamidino-2-phenylindole; FECH, ferroche-
latase; PPAT, phosphoribosylpyrophosphate amidotransferase; NTHL1,
nuclear endonuclease III-like protein 1; SDH, succinate dehydrogenase;
LIAS, lipoic acid synthase; GCSH, glycine cleavage system H; TCA, tricarbox-
ylic acid; PFK-1, phosphofructokinase-1; AXP, adenosine mono-, di-, and
tri-phosphate; ACC, acetyl-CoA carboxylase; DFO, desferrioxamine; HRCE,
human renal cortical epithelial; bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-
(hydroxymethyl)propane-1,3-diol; p-, phosphorylated.
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harvested following either no treatment or 24 or 36 h of
induction of transgene expression. Immunoblotting
revealed that IRP2 protein levels were greatly increased in
cells expressing ISCU2D71A or ISCU2C69S, whereas expres-
sion levels of IRP1 protein were unchanged, consistent with
the differential modes of activation of the IRPs under iron-
deficient conditions; c-aconitase loses its Fe-S cluster and
converts into an IRE-binding protein (24), whereas IRP2
protein is stabilized in iron-deficient cells, as it is not rapidly
degraded by the iron-dependent, FBXL5-mediated ubiquiti-
nation and proteasomal degradation pathway (25, 26)
(Fig. 2C). We also evaluated expression of proteins
of the cytosolic iron–sulfur assembly pathway, CIAO1,
FAM96B, and FAM96A (27), and found that levels of these
proteins were moderately increased in cells expressing
ISCU2D71A or ISCU2C69S for 24 or 36 h (Fig. 2D; Fig. S6). The
Figure 1. ISCU mutants disrupt cell growth and mitochondrial morphology. A–C, model of the Fe-S cluster ligating residues in the ISCU scaffold and
predicted positions of the altered residues in the mutant proteins. D, immunoblots of total protein lysates showing expression of ISCU and the accessory Fe-S
assembly factors cysteine desulfurase NFS1, the structural protein ISD11, and frataxin. *, predicted uncleaved mitochondrial precursor proteins; **, predicted
protein degradation fragments. E, immunoprecipitation of recombinant ISCU protein using anti-Myc beads showed that NFS1 and ISD11, but not frataxin, were
bound in a stable complex. F, real-time cell proliferation analysis revealed no change in cell growth following induction of ISCU2WT protein expression, whereas
induction of ISCU2D71A or ISCU2C69S expression resulted in diminished cell proliferation. Arrows, time of addition of either vehicle (water) or 1 g/ml doxycy-
cline. Cell growth was monitored using an Incucyte FLR instrument (see “Experimental procedures”; n  5, mean  S.D.). G–J, EM demonstrated significant
mitochondrial swelling and distorted cristae in cells induced to express ISCU2D71A or ISCU2C69S for 24 h.
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molecular pathway underlying these changes in protein
expression is the subject of a separate study (28).
Overexpression of ISCU2D71A and ISCU2C69S caused decreased
abundance and activity of Fe-S and lipoate-containing
proteins
Cells expressing ISCU2D71A and ISCU2C69S showed a pro-
found misregulation of cellular iron homeostasis as assessed by
increased IRE-binding activity of IRP1 and IRP2 (Fig. 2B) and
loss of activity of cytosolic and mitochondrial aconitases. We
analyzed the expression and activities of several other Fe-S pro-
teins (Fig. 3A), including the mitochondrial enzyme ferroche-
latase (FECH), cytosolic glutamine-phosphoribosylpyrophos-
phate amidotransferase (PPAT), and nuclear endonuclease III-
like protein 1 (NTHL1). The abundance of these Fe-S proteins
was markedly decreased in cells expressing ISCU2D71A and
ISCU2C69S (Fig. 3A). In contrast, levels of CIV-IV (complex IV
subunit 4), which does not possess an Fe-S cluster, were rela-
tively unchanged (Fig. 3A). We next evaluated the activity of
mitochondrial complex II by performing BN-PAGE and assay-
ing for succinate dehydrogenase (SDH) activity. Our data
showed a marked decrease in SDH activity in cells expressing
ISCU2D71A and ISCU2C69S that was associated with decreased
levels of the Fe-S cluster– containing subunit SDHB (Fig. 3B).
In contrast, levels of the SDH flavoprotein subunit SDHA as
well as mitochondrial import receptor subunit TOM20 were
unchanged (Fig. 3B). Complex I activity was also significantly
reduced in cells expressing ISCU2D71A and ISCU2C69S (Fig.
3C), as were protein levels of the Fe-S– containing complex I
subunit NDUFS1 (Fig. 3C). In contrast, NFS1 protein levels
remained unchanged (Fig. 3C).
The activity of several crucial mitochondrial enzymes
depends on the cofactor lipoic acid, which must be enzymati-
cally generated from octanoic acid by the addition of two sulfur
atoms at the C6 and C8 positions before covalent attachment to
lipoate-dependent enzymes (29, 30). Lipoic acid synthase
(LIAS) possesses two [4Fe-4S] clusters per subunit that are cru-
cial for its enzymatic activity (31, 32). Protein levels of LIAS
were profoundly decreased in cells expressing ISCU2D71A and
ISCU2C69S (Fig. 3D). Using an antibody specific for lipoylated
lysine residues in proteins, we found that lipoylation of several
proteins was variably decreased; the 62-kDa E2 dihydroli-
poyllysine-residue subunit of pyruvate dehydrogenase (DLAT)
was about 50% decreased, whereas the 49-kDa dihydrolipoyl-
lysine residue subunit of -ketoglutarate dehydrogenase
(DLST), 49-kDa lipoamide acyltransferase component of
branched-chain -keto acid dehydrogenase complex (DBT)
(Fig. 3D), and the 12-kDa glycine cleavage system H (GCSH)
subunit were more markedly decreased (Fig. 3E). Immunoblots
did not reveal decreased total protein levels of these enzymes in
the Fe-S– deficient cells expressing ISCU2D71A and ISCU2C69S
(Fig. 3F); rather, total protein levels of DLAT and DLST showed
a moderate increase (Fig. 3F). Decreased lipoylation of proteins
was also observed in muscle biopsies from patients with defec-
tive Fe-S cluster assembly due to long-term deficiency of ISCU
(Fig. S1) (7, 20). Notably, loss of lipoylation of the pyruvate
dehydrogenase subunit DLAT was more severe in these muscle
biopsies (Fig. S1A). Total protein levels of the lipoate-contain-
ing enzyme subunits were not decreased in skeletal muscle (Fig.
S1B), and mRNA expression levels for LIAS and lipoate-con-
taining subunits significantly increased (Fig. S1D), suggesting
that the lipoate synthesis pathway may have been up-regulated
in response to defective lipoylation of target enzymes.
Elevated intracellular citrate in Fe-S– deficient cells
The widespread loss of Fe-S– and lipoate– dependent
enzymes was expected to result in changes in the abundance
and flux of intracellular metabolites. To identify which central
Figure 2. Loss of aconitase activity and activation of iron-regulatory pro-
teins in cells expressing dominant–negative ISCU mutants. A, aconitase
activity gel demonstrated decreased mitochondrial and cytosolic aconitase
activities in cells expressing ISCU2D71A or ISCU2C69S following a 24-h incuba-
tion with doxycycline. B, analysis of ferritin IRE binding activity of IRP1 and
IRP2 by an electrophoretic mobility shift assay demonstrated increased IRP
activity in cells expressing ISCU2D71A or ISCU2C69S. C, immunoblot analyses of
protein levels in cells expressing ISCU2D71A or ISCU2C69S for either 24 or 36 h
demonstrated robust stabilization of IRP2 protein in cells expressing
ISCU2D71A or ISCU2C69S, whereas IRP1 protein abundance was unchanged. D,
protein abundance of CIAO1, FAM96B, and FAM96A were also evaluated by
immunoblot. -tubulin was the loading control for cytosolic proteins.
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metabolic pathways were most adversely affected, we per-
formed a glucose tracer experiment in which proliferating con-
trol HEK293 cells harboring the empty vector or cells express-
ing the ISCU2D71A mutant for 12 h were switched to tracer
medium containing [13C6] glucose and incubated for a further
24 h and then rapidly quenched with cold acetonitrile and
extracted for metabolite analysis (Fig. 4A). 1H-{13C} HSQC
NMR analysis of polar extracts of these cells revealed numerous
changes in the distribution of carbon derived from the
[13C6]glucose tracer following the 24-h labeling period (Fig.
4B). Notably, NMR analysis suggested that intracellular
[13C6]glucose/glucose 6-phosphate levels increased in cells
expressing ISCU2D71A (Fig. 4B), whereas several positions of
the adenine ring (8, 2) in AXP and the ribose ring (1) of AXP
showed significantly less 13C signal (Fig. 4B), suggesting that
purine synthesis was diminished, probably due to loss of
[4Fe-4S]-containing PPAT enzyme activity (discussed fur-
ther below). Finally, prominent doublet peak resonances at
2.66 and 2.69 ppm consistent with 13C labeling of the 2-
and/or 4-position of citrate were observed in cells expressing
ISCU2D71A, whereas only a smaller apparent triplet reso-
nance (2.65, 2.68, 2.70 ppm) was observed in control cells,
corresponding to 13C labeling of aspartate as well as citrate
and malate (Fig. 4B).
Figure 3. Widespread loss of Fe-S and lipoate-dependent proteins in cells expressing dominant–negative ISCU mutants. A, cells expressing ISCU2D71A
or ISCU2C69S for either 24 or 36 h showed decreased protein levels of Fe-S enzymes in mitochondria (FECH), cytosol (PPAT), and nucleus (NTHL1) and a robust
decrease in mitochondrial and cytosolic aconitase activities. B, analysis of complex II activity by in-gel activity assay revealed decreased SDH enzyme activity in
cells expressing ISCU2D71A or ISCU2C69S. Immunoblots demonstrated decreased SDHB protein levels, but SDHA protein levels were unchanged in cells
expressing ISCU2D71A or ISCU2C69S. Immunoblotting of TOM20 served as the loading control for mitochondrial proteins. C, in-gel assay of NADH-tetrazolium
reductase activity showed decreased complex I activity in cells expressing ISCU2D71A or ISCU2C69S for 24 and 36 h. Immunoblotting showed decreased
abundance of the complex I core subunit, NDUFS1, but no change in levels of cysteine desulfurase NFS1. Immunoblots revealed decreased protein levels of
LIAS and decreased lipoylation of the subunits of pyruvate dehydrogenase (DLST) and -ketoglutarate dehydrogenase (DLAT) (D) and GCSH (E). F, further
immunoblotting showed that total protein levels of these subunits were not decreased.
Metabolic reprogramming in acute Fe-S cluster deficiency
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To further evaluate the metabolic alterations arising from
overexpression of ISCU2D71A, we used GC-MS to measure the
total abundance and 13C enrichment of tricarboxylic acid
(TCA) cycle metabolites from the same polar cell extracts that
were used for the NMR analysis described above. The most
striking change observed in these analyses was an 11-fold
increase in intracellular citrate levels in cells expressing
ISCU2D71A (Fig. 4C), resulting in a marked elevation of cellular
citrate concentrations to levels higher than most other mea-
sured metabolites (e.g. 168 nmol/mg protein citrate versus 10
nmol/mg for other TCA cycle intermediates in ISCU2D71A
cells; see Fig. 4C and Fig. S2). Intracellular levels of cis-aconitate
were also substantially increased, whereas -ketoglutarate lev-
els decreased significantly in ISCU2D71A cells (Fig. 4C and Fig.
S2). Most (65%) of the elevated citrate in cells expressing
ISCU2D71A contained two additional mass units (m2; Fig.
4D), indicating that this pool of citrate arose from condensation
of [13C6]glucose-derived acetyl-CoA generated from residual
pyruvate dehydrogenase activity with unlabeled oxaloacetate
via the citrate synthase reaction (Fig. 4E and Fig. S2). This m2
citrate accumulated in cells expressing ISCU2D71A because
both mitochondrial and cytosolic aconitase activities were
undetectable in the ISCU2D71A cells (Figs. 2A and 3A), leading
to citrate accumulation as well as depletion of the downstream
product -ketoglutarate (Fig. 4C and Fig. S2). Significant quan-
tities of the m4 citrate isotopologue were also observed in
ISCU2D71A cells (Fig. 4D), probably due to residual amounts of
aconitase-mediated TCA cycle activity present early in the 13C
labeling period (Fig. 4E and Fig. S2).
Citrate is a known allosteric inhibitor of the glycolytic
enzyme phosphofructokinase-1 (PFK-1) (33, 34), and elevated
citrate decreased the rate of glycolysis in several in vivo animal
studies (33, 35). We analyzed glycolytic metabolites in our polar
cell extracts and observed a 93% decrease in the product of
the PFK-1 reaction, fructose 1,6-bisphosphate, in cells express-
ing ISCU2D71A relative to control empty vector– containing
cells (Fig. 4F). Downstream glycolysis intermediates 1,3-bis-
phosphoglycerate, 2- and 3-phosphoglycerate, and phosphoe-
nolpyruvate also decreased, albeit to a lesser extent than fruc-
tose 1,6-bisphosphate, possibly indicating replenishment of
these intermediates by glyceraldehyde 3-phosphate derived
from flux of glucose through the pentose phosphate pathway.
Consistent with our observations in the NMR spectra (Fig. 4B),
increased amounts of intracellular glucose/hexoses as well as
decreased lactate levels were observed in cells expressing
ISCU2D71A (Fig. 4G), suggesting that glycolysis rates decreased.
Levels of GlcNAc-phosphate, UDP-GlcNAc, UDP-GalNAc,
and 6-phosphogluconate in ISCU2D71A cells increased 6-, 3-,
6-, and 3-fold relative to control, respectively (Fig. 4, H and I),
indicating that glucose-derived carbon was significantly
diverted into both the glucosamine and oxidative pentose phos-
phate pathways. Finally, our analyses revealed a significant
decrease in total cellular AMP and ADP levels in cells express-
ing ISCU2D71A, whereas total ATP levels in these cells were not
different from control cells (Fig. 4I), suggesting that adenylate
homeostasis was altered in our acutely Fe-S cluster– deficient
cells.
In-depth analysis of de novo purine biosynthesis by UHR-
FTMS demonstrated intracellular buildup of the PPAT sub-
strate 5-phosphoribosyl pyrophosphate (Fig. S3B), whereas
total amounts and 13C incorporation from glucose into down-
stream de novo purine biosynthesis intermediates 5-phospho-
ribosyl-N-formylglycinamide, IMP, and adenylosuccinate
decreased sharply in cells expressing ISCU2D71A (Fig. S3, D–F).
We observed a sharp attenuation in 13C incorporation into the
isotopologues of the adenylates AMP, ADP, and ATP (Fig. S3,
G–I) and statistically significant decreases in total amounts of
total ADP and AMP, but not ATP (Fig. 4J). Total cellular ATP
concentrations appeared to be maintained by the presence of a
larger pool of unlabeled, previously synthesized ATP (Fig. S3G),
resulting in an increase in the total cellular ATP/ADP ratio
from 7.3  0.2 in control cells to 16.4  0.9 in cells expressing
ISCU2D71A.
Lipid biosynthesis in Fe-S– deficient cells
The robust increase in 13C-labeled citrate concentration in
cells expressing ISCU2D71A suggested that non-Fe-S– depen-
dent enzymatic reactions that utilize citrate might be stimu-
lated. In particular, lipid biosynthesis can proceed when ATP-
citrate lyase generates cytosolic acetyl-CoA from citrate driven
by ATP hydrolysis. To calculate the predicted enrichment of
lipids from [13C6]glucose during the tracer experiment
expected for maintenance of cellular homeostasis, we first
quantified the precise differences in cellular proliferation rate
(Fig. 5A). During the [13C6]glucose labeling period, control cells
underwent 1.12  0.07 population doublings, whereas cells
expressing ISCU2D71A underwent only 0.16  0.01 population
doublings (Fig. 5B). Using these data, we calculated that the
maximum expected enrichment in lipids from [13C6]glucose
would be 52% in control cells, whereas cells expressing
ISCU2D71A, which had largely ceased to proliferate, would have
been expected to show a lipid 13C enrichment of just 14%.
To assess the actual incorporation of [13C6]glucose-derived
carbon into lipids during the [13C6]glucose tracer experiment,
we performed 1H-{13C}- HSQC NMR analyses on the lipid frac-
tions extracted from HEK293 cells expressing empty vector or
Figure 4. Increased cellular citrate levels in Fe-S– deficient cells. A, HEK293 cells harboring either empty vector or ISCU2D71A were induced with doxycycline
treatment 12 h before metabolic labeling for 24 h with 25 mM [13C6]glucose. B, incorporation of [
13C6]glucose into cellular metabolites in cells expressing either
empty vector or ISCU2D71A was assessed by 1H-13C HSQC NMR. Spectra are normalized to total cellular protein content measured by a BCA assay (see
“Experimental procedures”). C, total cellular quantities of TCA cycle intermediates were assessed by GC-MS, revealing an 11.4-fold increase in intracellular
citrate (n  4, mean  S.D. (error bars)). D, analysis of the fractional distribution of citrate isotopologues by GC-MS showed a 15.2-fold increase in the m2
fraction of citrate derived from [13C6]glucose in cells expressing ISCU2
D71A (n  3, mean  S.D.). E, the predominant metabolic pathway leading to increased
citrate levels in cells expressing ISCU2D71A. The large increase in m2 citrate suggested that the majority of the increased cellular citrate was a result of the
combined action of pyruvate dehydrogenase and citrate synthase reactions together with the loss of aconitase activity. Shown is analysis of glycolytic
intermediates by IC-UHR-FTMS (F); hexoses and lactate (G); hexosamines GlcNAc 1/6-phosphate (GlcNAc-P), UDP-GlcNAc, and UDP-GalNAc (H); and pentose
phosphate pathway metabolites (I) (n  4; percentage of control  S.D.). J, levels of adenylates ATP, AMP, and ADP in empty vector control and ISCU2D71A cells.
*, p  0.05; **, p  0.01.
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ISCU2D71A (Fig. 5C). These fractions contain complex lipids in
the form of triacylglycerols and glycerophospholipids as well as
cholesterol and its esters. The spectra revealed that cells bear-
ing either the empty vector or the ISCU2D71A synthesized new
complex lipids, as both the fatty acyl chains and the glycerol
subunits were much more intense than the unlabeled cells (Fig.
5C). Furthermore, the 13C intensities of the lipids in the
[13C6]glucose experiments were similar in both the fatty acyl
chains and the glycerol subunit in the control and ISCU2D71A
samples (Fig. 5E), suggesting that robust synthesis of lipids from
[13C6]glucose proceeded in ISCU2D71A cells, although they had
ceased to proliferate. This is quite different from purine nucle-
otide biosynthesis, which largely ceased in the ISCU2D71A cells
(see above). However, the incorporation of glucose-derived 13C
into cholesterol methyl groups was significantly lower in
ISCU2D71A cells (Fig. 5E), suggesting that cholesterol biosyn-
thesis decreased, whereas the natural abundance choline
methyl groups were on average 25% greater in the ISCU2D71A
extracts (Fig. 5E), suggesting a small increase in total membrane
phospholipids in these extracts.
To directly evaluate the 13C fractional enrichment of selected
lipid functional groups in [13C6]glucose-labeled cells express-
ing empty vector or ISCU2D71A sequences, we quantified peak
areas in selected regions of 2D TOCSY NMR spectra corre-
sponding to the glycerol subunit and the fatty acyl chains, as
shown in Fig. S4 (A and B). 13C enrichment in the three glycerol
carbons was 49.7  4.7% in the control sample and 41.7  3.2%
in the ISCU2D71A sample, whereas the fatty acyl chains reached
13C enrichment at the -methyl position of 11.0% in the empty
vector control sample and 15.5% in the ISCU2D71A sample. The
low 13C enrichment of -methyl groups in WT HEK293 cells
suggests that they derived substantial components of their cel-
Figure 5. Lipid biosynthesis proceeded in Fe-S– deficient cells despite lack of cell growth. A, ISCU2D71A cells were plated at a higher initial seeding density
to obtain comparable amounts of cells at the end of the experiment, and cell proliferation was monitored by real-time imaging (n  6, mean  S.D. (error bars)).
B, analysis of cell proliferation during the [13C6]glucose tracer experiment demonstrated that growth of cells was greatly diminished after 12 h of doxycycline-
induced induction of ISCU2D71A expression (n  6, mean  S.D.). C, representative lipid HSQC NMR spectra from [13C6]glucose-labeled cells expressing empty
vector (black trace) or ISCUD71A (blue trace). Unlabeled empty vector cells (gray) grown in the presence of unlabeled [12C]glucose are also shown for reference.
These spectra reflect the combined resonances from all extracted lipid species in the sample. D, a glycerolipid structure is shown for partial HSQC NMR peak
assignment. Side chain R can include a third acyl chain (triacylglycerol), a proton (diacylglycerol) phosphatidylcholine, phosphatidylethanolamine, etc. E, 13C
enrichment of the various lipid functional groups was assessed by 1H-13C HSQC NMR. Integrated peak areas were normalized to the methanol solvent peak and
plotted as a percentage of control (empty vector) peak areas (n  3, mean  S.D.). *, p  0.05.
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lular lipid content from sources other than glucose under stan-
dard culture conditions (36, 37). In contrast, cells expressing
ISCU2D71A showed 13C enrichment in their lipids that was far
greater than expected when compared with the calculated max-
imum expected 13C enrichment values reported above, further
demonstrating that de novo lipid biosynthesis proceeded in
Fe-S cluster– deficient ISCU2D71A cells despite their greatly
diminished proliferation.
To evaluate potential changes in the regulation of enzymes
involved in fatty acid biosynthesis, we performed Western blot-
ting using the protein residues that were obtained during our
[13C6]glucose tracer experiment. Notably, the phosphorylation
status of the energy-sensing protein kinase AMPK and its tar-
get acetyl-CoA carboxylase (ACC1/2) did not change apprecia-
bly during the tracer experiment (Fig. S5, A and B), despite the
profound changes in cellular metabolism brought on by Fe-S
deficiency in ISCU2D71A cells. In contrast, Western blots con-
firmed decreased lipoylation of -ketoglutarate dehydrogenase
(Fig. S5C) as well as decreased abundance of the Fe-S–
containing complex II subunit SDHB (Fig. S5D), confirming
that Fe-S deficiency occurred during the tracer experiment.
Notably, significant quantities of the pyruvate dehydrogenase
subunit, DLAT, remained lipoylated at the end of the tracer
experiment, thus allowing for the large accumulation of m2
citrate in ISCU2D71A cells.
Lipid droplet accumulation in Fe-S– deficient and iron-
deficient cells
The above data suggested that significant glycerolipid bio-
synthesis proceeded in Fe-S cluster– deficient ISCU2D71A cells
despite the nearly complete termination of cell growth. This
suggested that newly formed fatty acids in ISCU2D71A cells
might be used for purposes other than making new cell mem-
branes. A distinct possibility is the formation and accumulation
of lipid droplets (22). To spatially evaluate cellular lipid distri-
bution, we visualized lipids in control cells and in cells express-
ing ISCU2D71A using BODIPY 493/503 staining and fluores-
cence microscopy (Fig. 6). In uninduced HEK293 control cells,
the BODIPY staining pattern was consistent with labeling of
endoplasmic reticulum and plasma membrane, and few lipid
droplets were observed (Fig. 6A). In contrast, cells induced to
express ISCU2D71A or ISCU2C69S for 48 h showed accumula-
tion of numerous small lipid droplets throughout the cytoplasm
(Fig. 6, B and C). These data suggested that lipid droplets might
constitute a storage depot for the de novo synthesized lipids in
Fe-S– deficient cells. To test this further, we subjected HEK293
cells to acute iron deficiency for 24 h by treatment with the iron
chelator desferrioxamine (DFO) and assayed for lipid droplet
formation using BODIPY. Similar to expression of ISCU2D71A
or ISCU2C69S, 24-h treatment of cells with DFO results in
Figure 6. Lipid droplet accumulation in Fe-S– deficient and iron-deficient cells. BODIPY staining was used to assess the presence of lipid droplets in
HEK293 cells. A, ISCU2D71A cells without the addition of doxycycline. B, ISCU2D71A cells treated with doxycycline for 48 h. C, cells expressing ISCUC69S treated with
doxycycline for 48 h. D, parental HEK293 control cells. E, HEK293 cells treated with 100 M DFO for 24 h. F, HEK293 cells treated with 300 M DFO for 24 h. G–I,
primary cells derived from human kidney cortex tissue (HRCE cells) were treated with 0, 50, or 150 M DFO for 48 h and stained for lipid droplets with BODIPY.
The green channel shows BODIPY staining of cellular lipids, whereas the blue channel shows nuclei stained with DAPI. Bar, 10 m.
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strong depletion of mitochondrial and cytosolic aconitase
activities in cultured cells (19). In contrast to control cells,
which showed very few lipid droplets (Fig. 6D), HEK293 cells
treated with 100 or 300 M DFO showed robust accumulation
of cytoplasmic lipid droplets (Fig. 6, E and F). Finally, strong
accumulation of lipid droplets was also seen in primary human
renal cortical epithelial (HRCE) cells treated with 50 and 150
M DFO (Fig. 6, G–I). Notably, HRCE cells are nontransformed
primary cells and do not possess any known genetic
abnormalities.
Discussion
To date, biological studies of the human Fe-S cluster scaffold
ISCU have relied on RNAi-mediated knockdown strategies
(19), genetic studies in model organisms (17), and hypomorphic
human disease models (7, 8, 20, 21). We reasoned that the acute
effects of Fe-S cluster deficiency on cellular metabolism would
be most clearly observed using a system that disrupted cellular
Fe-S cluster biosynthesis more rapidly and completely. We
engineered inducible dominant–negative forms of the ISCU
scaffold in human cells that acutely disrupt the function of
recipient Fe-S proteins, resulting in rapid loss of Fe-S proteins
in multiple cellular compartments as well as decreases in
lipoate-dependent mitochondrial enzymes. The major pheno-
typic effects resulting from acute Fe-S depletion were loss of
proliferative ability, increased citrate levels, decreased overall
metabolic rates, and increased deposition of newly synthesized
lipids into cytoplasmic lipid droplets.
The rapid and acute loss of aconitase activity caused a dra-
matic increase in cellular glucose-derived citrate, which is a
known allosteric inhibitor of PFK-1 (33, 34). Inhibition of
PFK-1 by elevated citrate leads to accumulation of glucose
6-phosphate and decreased rates of glycolysis in diabetic animal
muscles and during oxidation of fatty acids and ketone bodies
in various tissues (33, 35). This acute, hormone-independent
reciprocal control of intracellular glucose and fatty acid oxida-
tion by citrate is part of a regulatory pathway termed the Randle
cycle (38). We found that citrate accumulation caused by aco-
nitase deficiency was an early and acute metabolic consequence
of Fe-S cluster deficiency in ISCU2D71A-expressing HEK293
cells. Our data demonstrated that the immediate metabolic
consequences of the 10-fold increase in intracellular citrate in
Fe-S– deficient cells included acute inhibition of glycolysis at
the level of PFK and the shunting of glucose 6-phosphate into
the pentose phosphate pathway, probably enhancing produc-
tion of NADPH in the cytosol. We also observed shunting of
glucose carbon into hexosamines including UDP-GlcNAc,
which is the donor molecule for glycosylation of cellular pro-
teins. Recently, increased glycosylation of PFK-1 under hypoxic
conditions was shown to decrease PFK-1 activity, leading to
increased glucose flux through the pentose phosphate pathway
(39). Thus, increased glycosylation of PFK-1 induced by the
3-fold increase in UDP-GlcNAc levels in our Fe-S– deficient
cells probably contributed to shunting of glucose into the pen-
tose phosphate pathway.
Increased citrate cleavage by ATP-citrate lyase in the cytosol
probably resulted in abundant cytosolic acetyl-CoA and forma-
tion of malonyl-CoA by ACC1/2, leading to de novo fatty acid
biosynthesis. Together, these metabolic alterations explain our
observation that de novo biosynthesis of lipids from glucose-
derived carbon proceeded in the Fe-S– deficient cells, although
the cells had ceased to proliferate. These observations led us to
discover that acute iron and/or Fe-S cluster deficiency resulted
in formation of abundant cytosolic lipid droplets, a phenotype
typically observed only following supplementation with excess
exogenous lipids or fatty acids such as palmitate. Our observa-
tions support the concept that ISCU is crucial for the function
of Fe-S proteins in all cellular compartments and that cellular
carbon flux can be diverted to iron-independent pathways
when Fe-S clusters are unavailable for recipient Fe-S proteins.
A major question raised by our work is whether fatty acid
biosynthesis may provide an iron-independent enzymatic path-
way for energy storage when cellular iron and/or Fe-S clusters
are acutely deficient. Diversion of a portion of the glucose-de-
rived citrate to lipid droplets may have provided a way for the
cells to divert and store fuel-derived carbon when the aconita-
ses were inactivated (Fig. 7). In this manner, fatty acids could be
thought of as a terminal electron acceptor for reduced cofactors
(e.g. NAD(P)H) and storage of glucose-derived energy during
acute Fe-S cluster deficiency. Citrate allosterically activates
acetyl-CoA carboxylases ACC1/2 (40), whereas phosphoryla-
tion by AMPK and other kinases leads to rapid inactivation of
ACC1/2 (41). The elevated citrate and lack of change in
ACC1/2 phosphorylation status suggest that the biochemical
conditions were favorable for de novo fatty acid biosynthesis in
our Fe-S– deficient cells. Notably, none of the enzymes of gly-
colysis, the pentose phosphate pathway, or the core steps of
fatty acid biosynthesis have been reported to require iron or
Fe-S clusters for their activity. Thus, the machinery required for
maintenance of adequate ATP and NADPH production for
lipid biosynthesis remained functional in our Fe-S– and iron-
deficient cells. However, continued uptake of exogenous lipids
and impairment of fatty acid oxidation probably also contrib-
uted significantly to lipid droplet formation in our Fe-S cluster–
deficient cells (Fig. 7).
Another notable finding in our work concerns the apparent
differences in the rate of inactivation of lipoate-containing
enzymes that occurred due to loss of the LIAS enzyme. In cells
expressing ISCU2D71A, where Fe-S cluster deficiency occurred
for a maximum of only 36 h, lipoylated pyruvate dehydrogenase
was still relatively abundant, allowing for continued production
of mitochondrial acetyl-CoA and citrate, export to the cytosol
and accumulation of m2 citrate, and cytosolic generation of
acetyl-CoA by the cleavage of the citrate. In contrast, ISCU
myopathy patient muscle biopsies showed nearly complete loss
of pyruvate dehydrogenase lipoylation, probably a consequence
of long-term Fe-S cluster and LIAS deficiency. Our data
strongly suggest that a prolonged muscle-specific defect in
lipoic acid synthesis contributes to the unique disease pheno-
type in ISCU myopathy patients due to loss of LIAS activity, as
recently suggested (42). We also note that a prolonged inability
to oxidize NADH in ISCU myopathy patient muscles probably
resulted in a functional deficit of cellular NAD that may have
resulted in the strong up-regulation of the NAD biosynthetic
enzyme quinolinate phosphoribosyltransferase observed previ-
ously in these tissue biopsies (21). Finally, several recent papers
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have reported an interaction between the mitochondrial acyl
carrier protein and Fe-S cluster assembly machinery compo-
nents NFS1 and ISD11 (43, 44). It will be interesting to further
investigate interactions between the acyl carrier protein
domain of the cytosolic fatty acid synthase and the cytosolic
Fe-S cluster assembly machinery, recently reported by Kim et
al. (28).
Overaccumulations of lipid droplets in nonadipose tissues,
such as heart, liver, and certain tumors, are clinically significant
problems that are poorly understood (45–47). In models of
Friedreich’s ataxia, lipid droplet accumulation has been
reported in frataxin-deficient cardiac muscle (48), isolated car-
diomyocytes (49), and frataxin-deficient mouse livers (50).
Additionally, large lipid droplet accumulation was observed in
glial cells in a Drosophila model of Friedreich’s ataxia (51).
Recent studies suggest that between 30 and 40% of adults in the
United States are affected by nonalcoholic fatty liver disease
(52), and a significant fraction of these individuals will progress
to nonalcoholic steatohepatitis, potentially leading to cirrhosis
and hepatocellular carcinoma. Interestingly, nonalcoholic ste-
atohepatitis has recently been linked to iron-deficiency anemia
(53–55).
In our studies, treatment of cells with the iron chelator DFO,
which is known to rapidly result in strong loss of cytosolic and
mitochondrial aconitase activities (19), caused a robust accu-
mulation of cytoplasmic lipid droplets. Whereas the effect of
DFO in curbing cellular iron availability in our in vitro studies
was probably stronger and more rapid than any living tissue
could experience, it suggests that lipid accumulation due to
iron deficiency in animals could occur through a similar mech-
anism by causing loss of activity of aconitase enzymes. Notably,
inactivation of aconitase by mitochondrial reactive oxygen spe-
cies resulted in elevated citrate and lipid droplet formation in
an in vitro model of fructose-induced nonalcoholic fatty liver
disease (56), whereas elevated oxidative stress in Sod1	/	 pri-
mary hepatocytes also triggered lipid droplet formation (57).
Significant elevations in citrate have also been reported in clear
cell renal cell carcinoma (58), a tumor in which the defining
histological feature is cytoplasmic lipid droplet accumulation
(59). Thus, elucidation of the mechanisms of citrate and lipid
droplet accumulation in nonadipose tissues during disease
states may reveal important insights into the pathogenesis of a
significant number of poorly understood diseases.
Experimental procedures
Quantitative real-time PCR
Quantitative real-time PCR was performed using SYBR
Green (Applied Biosystems) according to the manufacturer’s
instructions, following reverse transcription of total RNA into
cDNA (Applied Biosystems). Relative transcript abundance
was calculated using the 2	

Ct method (60), with glyceralde-
hyde-3-phosphate dehydrogenase as the internal control. Non-
transformed 2	

Ct values were analyzed by paired t tests to
evaluate statistical significance relative to controls. The correct
quantitative real-time PCR product sizes were verified by aga-
Figure 7. Diversion of glucose-derived citrate to fatty acid biosynthesis in Fe-S– deficient and iron-deficient cells. A, in iron-replete cells with functional
Fe-S cluster assembly machinery, mitochondrial and cytosolic aconitases facilitate the flow of glucose-derived carbon through the TCA cycle and respiratory
chain, allowing for production of ATP via the respiratory chain. B, when Fe-S clusters are unavailable due to iron deficiency and/or disruption of the Fe-S cluster
assembly machinery, iron-dependent enzymes are inactivated, fatty acid oxidation cannot occur, and citrate cannot be converted to isocitrate via mitochon-
drial and cytosolic aconitases. Apo-c-aconitase/IRP1 activates cellular iron starvation responses via increased IRE mRNA-binding activity. However, biochemical
pathways that do not require iron cofactors, such as glycolysis, the pentose phosphate pathway, and fatty acid biosynthesis, remain active. The result is
accumulation of lipids in the form of cytoplasmic lipid droplets.
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rose gel electrophoresis, and melting curves were performed
after every experiment.
Tissue culture
HEK293 Flp-In cells (Gibco) and HRCE cells (Lonza) were
cultured in T-75 flasks (BD Falcon) in Dulbecco’s modified
Eagle’s medium, 10% fetal bovine serum, supplemented with 25
mM D-glucose, 2 mM L-glutamine, without added pyruvate, in a
humidified atmosphere of 5% CO2.
Cloning and site-directed mutagenesis
PCR primers were designed flanking the ISCU2 or emerald
green GFP (emGFP) protein coding sequence and included
additional sequences possessing a 5 HindIII recognition
sequence. The 3 primer sequences contained Myc tag seque-
nces and an XhoI cleavage site (Table S1). The amplified ISCU2
and emGFP ORFs as well as the pcDNA5/FRT/TO plasmid
were digested with HindIII and XhoI enzymes, and the prod-
ucts were purified by gel electrophoresis and ligated into
pcDNA5/FRT/TO, and plasmid insert identities were con-
firmed by Sanger sequencing. Site-directed mutagenesis of the
plasmid harboring hISCU2 was performed using standard tech-
niques, and subclones containing point mutations resulting in
hISCU2-D71A and hISCU-C69S were confirmed by sequenc-
ing. PCR primer sequences are listed in Table S1. Transgene
expression was induced by the addition of 2 g/ml doxycycline
to the growth medium, and cells were harvested and extracted
in nondenaturing lysis buffer.
ISCU myopathy patient skeletal muscle biopsies
Vastus lateralis skeletal muscle biopsies from adults were
obtained and prepared as described previously (7). Written
informed consent was given by all individuals involved in the
study in accordance with the Institutional Review Board of
the University of Texas Southwestern Medical Center and the
Texas Health Presbyterian Hospital of Dallas. All human study
procedures were performed in accordance with the principles
outlined by the Declaration of Helsinki.
Western blotting
SDS-PAGE and Western blotting were performed as
described previously (61) using 1.5-mm 4 –12% precast bis-Tris
gels (Invitrogen). Rabbit polyclonal anti-ferrochelatase serum
was a kind gift from Dr. Harry Dailey. Anti-IRP1, IRP2, PPAT,
ISCU, NFU, and NFS1 rabbit polyclonal sera were raised
against synthetic peptide fragments (19). SDH-B, SDH-A,
NDUFS1, and complex IV subunit 4 and frataxin antibodies
were from Mitosciences. Rabbit anti-Tom-20 was from Santa
Cruz Biotechnology. Rabbit anti-lipoate was from Chemicon.
Rabbit anti-total DLAT and DLST as well as p-AMPK, total
AMPK, p-ACC, and total ACC antibodies were from Cell Sig-
naling. Anti-total GCSH was from ProteinTech Group, Inc.
Anti-NTHL1 was from R&D Systems, Inc. Rabbit anti-citrate
synthase was from Sigma-Aldrich.
Electron microscopy
HEK293 cells were grown in standard culture medium on
borosilicate glass coverslips; treated as indicated; fixed with 2%
glutaraldehyde, 2% formaldehyde for 90 min in 0.1 M sodium
cacodylate, pH 7.2; postfixed in 1% osmium tetroxide; and
stained en bloc with 2% uranyl acetate overnight. Samples were
dehydrated in increasing concentrations of ethanol and pene-
trated with epoxy resin subsequently polymerized at 65 °C for
60 h. Coverslips were removed by treatment with hydrofluoric
acid, and blocks were cut out and remounted on a holder. Thin
sections were cut parallel to the surface of the block, mounted
on copper grids covered with Formvar/carbon film, and stained
with uranyl acetate and lead acetate. Samples were analyzed
with a FEI Tecnai T20 microscope at 120 kV, and images were
recorded with a Gatan US1000 CCD camera.
Aconitase in-gel assay and electrophoretic mobility shift assay
Aconitase was assayed using a coupled assay following native
PAGE separation, as described previously (19). IRP-IRE bind-
ing activity was determined by an electrophoretic mobility shift
assay using a 32P-labeled ferritin IRE probe, as described previ-
ously (19).
NMR and GC-MS analysis of polar cell extracts
Tracer experiments were carried out in triplicate with 25 mM
[13C6]glucose in Dulbecco’s modified Eagle’s medium contain-
ing 2 mM glutamine and 10% dialyzed fetal bovine serum, with-
out added sodium pyruvate. At the end of the tracing period,
cells were washed three times in cold PBS, quenched in cold
acetonitrile, and extracted in acetonitrile/water/chloroform
(2:1.5:1) (62). The upper polar metabolite fractions were frozen
in several aliquots each and lyophilized overnight. One fraction
of the resulting residue was reconstituted in 55 l of a mixture
of 50% H2O, 50% D2O containing 25 nmol of DSS-d6 and trans-
ferred to disposable 1.7-mm glass NMR tubes (Wilmad). NMR
spectra were recorded at 14.1 T, 20 °C, on an Agilent DD2 spec-
trometer, using standardized parameters as described previ-
ously (63, 64). Metabolite derivatization for GC/MS analysis
was performed with N-methyl-N-(tert-butyldimethylsilyl)
trifluoroacetamide, and analyses were performed with a
Thermo GC-ion trap MS system as described previously (65),
and spectra were processed and analyzed using Thermo Xcali-
bur software.
Polar metabolite analysis by IC-UHR-FTMS
IC-UHR-FTMS analyses were performed as described previ-
ously (66, 67) to assess 13C incorporation into various metabo-
lites. For metabolites quantified with purified standards, data
are expressed as nmol/mg protein. For metabolites for which a
purified standard was not available for quantification purposes,
compounds were identified by their exact mass, and data are
expressed as ion intensities normalized to the internal standard
(DSS-d6).
NMR analysis of lipids
A 1:1 mixture of chloroform and methanol containing 1 mM
butylated hydroxytoluene was added to the lower nonpolar
fractions obtained from the extracts described above, and the
mixtures were then dried in an Eppendorf SpeedVac (62). The
resulting lipid residues were dissolved in 210 l of methanol-d4,
vortexed vigorously, and centrifuged at 3000  g for 5 min, and
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the 200 l of supernatant was transferred to 3-mm methanol
susceptibility–matched Shigemi NMR tubes. 1H NMR spectra
were recorded with an acquisition time of 2 s and a relaxation
delay of 3 s with low-power irradiation to saturate the residual
HOD resonance. 1H-{13C} HSQC spectra were recorded with
an acquisition time of 0.2 s and a relaxation delay of 1.8 s,
with adiabatic decoupling. TOCSY spectra were recorded with
acquisition times of 1.0 s in t2 and 0.043 s in t1 using a spin lock
strength of 8 kHz for a duration of 50 ms. 1D spectra were
apodized using an unshifted Gaussian function with 1-Hz line
broadening exponential and one zero filling. The TOCSY spec-
tra were similarly apodized, with one zero filling in each dimen-
sion and one linear prediction in t1. 1H spectra were referenced
to the methanol proton resonance at 3.32 ppm, whereas 1H-13C
HSQC NMR spectra were referenced to the natural abundance
1H-13C butylated hydroxytoluene tert-butyl resonance at 1.40
ppm. The satellite positions in the glycerol and fatty acyl chains
were verified by the TOCSY experiment, and enrichments were
determined by volume integration (68) for a pair of 2D TOCSY
samples. A parametric unpaired Welch’s t test was used to com-
pare the control and ISCUD71A samples. 1D HSQC experiments
were used to estimate the relative 13C content of different lipid
functional group positions in all of the extracts. Peaks corre-
sponding to the terminal -methyl resonance (0.90 ppm), the
large saturated acyl methylene (e.g. C5–7,12–16) resonance
(1.29 ppm), the 2- and 3-methylene resonances of acyl chains
(2.33 and 1.60 ppm), the glycerol resonances (5.24, 4.45, 4.43,
4.17, and 4.00 ppm), cholesterol methyl groups (0.73 and 1.03
ppm), the unsaturated CC double bond (5.35 ppm) and the
adjacent vicinal protons (2.04 ppm), and the natural abundance
choline methyl groups (3.23 ppm) were integrated and normal-
ized to the solvent methanol 1H impurity resonance (3.31 ppm).
Normalized peak areas obtained for ISCU2D71A samples were
divided by the values obtained for the empty vector samples and
expressed as a percentage of control.
Analysis of cell proliferation
For proliferating cells, the expected enrichment assuming
constant lipid content per cell (cellular homeostasis) would be
determined by the number of cell divisions that occurred after
the cells were labeled with tracer. For one division, the enrich-
ment would be expected to be about 50%. A higher enrichment
would imply that additional synthesis and turnover occurred in
excess of that needed to maintain homeostasis. Relative 13C
enrichment of cellular lipids in the [13C6]glucose tracer exper-
iment was calculated assuming complete incorporation of glu-
cose into newly formed lipids and using the number of popula-
tion doublings that occurred during the experiment, as
measured by live-cell imaging using an Incucyte FLRTM instru-
ment in phase-contrast mode with the confluence overlay
application.
BODIPY staining and fluorescent microscopy
HEK293 cells were cultured in 4-well borosilicate chambers
and imaged with an EVOS FL inverted fluorescence microscope
(Life Technologies). Briefly, cells were incubated in treatment
media for 48 h, after which a mixture of Live Cell Imaging Solu-
tion (Life Technologies) was added to the cultures to allow for a
final concentration of 1 drop/ml NucBlue DAPI live-cell stain
and a 1:1000 dilution of freshly prepared and filtered 1 mg/ml
BODIPY 493/503 solution prepared in pure ethanol (Molecular
Probes). The cells were returned to the incubator for 10 min,
and then the staining solution was removed and replaced with
fresh Live Cell Imaging Solution, and the coverslips were
imaged at 400 in DAPI (10% illumination and 60-ms exposure
time) and GFP (60% illumination and 250-ms exposure time)
channels.
Western blotting densitometry
Densitometry was performed using Image Studio LiteTM ver-
sion 5.0 software configured for median background subtrac-
tion. Total protein loading was assessed by Ponceau S staining
immediately following the electrophoretic transfer of the pro-
teins to nitrocellulose membranes and quantified by perform-
ing densitometry on the stained proteins present in the 30 –70-
kDa region of the membrane. Western blotting band intensities
were normalized to the relative amount of quantified total pro-
tein and are presented as arbitrary density units.
Statistical analyses
Unless otherwise noted, a two-tailed Student’s t test was
applied to assess differences between experimental groups,
with equal variance assumed between groups. Sample sizes of
experimental groups were chosen based on the ability to
observe biologically relevant differences.
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